---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-099067"
form_type: "8-K"
ticker: "INO"
cik: "0001055726"
company_name: "INOVIO PHARMACEUTICALS, INC."
filed_at: "2024-04-17T23:59:59+00:00"
generated_at: "2026-06-03T21:28:48.592369+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Inovio priced ~$36M underwritten offering of common stock and pre-funded warrants

## Summary
- Priced 2,536,258 shares at $7.693/share and pre-funded warrants for 2,135,477 shares at $7.692/warrant.
- Gross proceeds ~$36M; net proceeds ~$33.2M after underwriting discounts and expenses.
- Offering led by Deep Track Capital; closes on or about April 18, 2024.
- Oppenheimer & Co. and Citizens JMP Securities acting as joint book-running managers.

## SEC filing metadata
- accession: 0001193125-24-099067
- form_type: 8-K
- ticker: INO
- cik: 0001055726
- company_name: INOVIO PHARMACEUTICALS, INC.
- filed_at: 2024-04-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1055726/000119312524099067/0001193125-24-099067-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1055726/000119312524099067/d817715d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-099067
- JSON: https://secwatch.observer/filing/0001193125-24-099067.json
- Plain text: https://secwatch.observer/filing/0001193125-24-099067.txt

## Key facts
- Material Agreements
  INOVIO PHARMACEUTICALS, INC. entered into Underwriting Agreement with Oppenheimer & Co. Inc. and Citizens JMP Securities, LLC, as representatives of the several underwriters named therein valued at approximately $33.2 million (effective 2024-04-15).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Oppenheimer & Co. Inc. and Citizens JMP Securities, LLC, as representatives of the several underwriters named therein
  - Value: approximately $33.2 million
  - Effective: 2024-04-15
  source text: On April 15, 2024, Inovio Pharmaceuticals, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Oppenheimer & Co. Inc. and Citizens JMP Securities, LLC, as representatives of the several underwriters named therein (collectively, the “ Underwriters ”), relating to the issuance and sale by the Company in an underwritten registered direct offering (the “ Offering ”) of 2,536,258 shares (the “ Shares ”) of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), at a price of $7.693 per share and pre-funded warrants to purchase up to 2,135,477 shares of Common Stock (the “ Pre-Funded Warrants ”) at a price of $7.692 per Pre-Funded Warrant, which represents the per share price for the Shares less the $0.001 per share exercise price for each Pre-Funded Warrant.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1055726/000119312524099067/0001193125-24-099067-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.